Clinical trials recruiting for MASLD
15
Recruiting trials
8
US states with sites
14
Countries
27%
Accept healthy volunteers
Phase breakdown
Early Phase 1 1Phase 2 1Not applicable 13
Drugs and treatments being studied
| Intervention | Trials |
|---|---|
| Digoxin | 1 |
| Fructose | 1 |
| Glucose | 1 |
| Pectin | 1 |
| Tirzepatide | 1 |
Where trials are recruiting (top US states)
| State | Recruiting trials |
|---|---|
| California | 1 |
| Connecticut | 1 |
| Massachusetts | 1 |
| Michigan | 1 |
| New Mexico | 1 |
| New York | 1 |
| Texas | 1 |
| West Virginia | 1 |
Top cities
Albuquerque, New Mexico 1Boston, Massachusetts 1Detroit, Michigan 1Houston, Texas 1La Jolla, California 1Morgantown, West Virginia 1New Haven, Connecticut 1New York, New York 1
Self-screener
Recruiting trials
- Accurate Point of Care Liver Disease Diagnostics (Phase 2)
- Acquisition of Cardiac Function Parameters in MRI and Echocardiography in Patients With Ethyltoxic Liver Cirrhosis and Transjugular Intrahepatic Portosystemic Shunt (TIPSS) Placement
- Development of a Non-invasive Screening Tool to Predict Metabolic Dysfunction-associated Steatotic Liver Disease
- Digital Early Warning System for Acute Lung Injury in Liver Surgery
- Digoxin In NASH (CODIN)
- Effect of Endoscopic Sleeve Gastroplasty in Patients With Obesity and MASH: A Randomized Controlled Trial
- Effect of Tirzepatide on Markers of MASLD in Patients With Obesity
- Effects of Peanut Consumption on Adults With Metabolic Associated Fatty Liver Disease
- Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease
- Evaluation of a New Ultrasound System for the Non-invasive Assessment of Liver Steatosis in MASLD/MASH Patients
- Global Research Initiative for Patients Screening on MASH
- Hepatic Gene Response to Intravenous Glucose in Obese Patients With and Without MASLD Undergoing Bariatric Surgery
- High Fructose Diet, the Gut Microbiome, and Metabolic Health
- NAFLD Clinical Care Pathway
- The Impact of Pectin Supplementation on Systematic Inflammation Pathway, Gut Microbiome, and Metabolic Health in Patients With Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD)
Related conditions
Trials recruiting for MASLD often also study these conditions. Each links to its own recruiting-trial list.
NASH 218Obesity 1512Type 2 diabetes 891NAFLD (Nonalcoholic Fatty Liver Disease) 5MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) 11MASH 6Fatty Liver 17Metabolic Dysfunction-Associated Steatotic Liver Disease 13MASH With Fibrosis 3MASH - Metabolic Dysfunction-Associated Steatohepatitis 8
Common questions
Are these trials free to join?
Study-related care in a clinical trial is usually provided at no cost to participants, and some trials reimburse travel. Costs vary by study - the trial team will explain what is and is not covered. Confirm this directly with them.
How do I know if I am eligible for MASLD trials?
Each trial lists inclusion and exclusion criteria. The screener above checks stated age and sex only. The full eligibility (your medical history, current medications, test results) is assessed by the study team. Open any trial to read its criteria, then contact the site.
Is this list complete?
No. For the full list, search ClinicalTrials.gov.